Ligand-independent activation of oestrogen receptor α by caveolin-1

Biochemical Journal

Volumn 359, Issue 1, 2001, Pages 203-210

  Schlegel, A ^a   Wang, C ^a   Pestell, R G ^a   Lisanti, M P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Caveolae; Receptor activation; Sex hormone receptors; Signal transduction

Indexed keywords

DNA; ENZYMES; MUTAGENESIS;

OESTROGEN RECEPTORS;

GENES;

CAVEOLIN 1; CELL NUCLEUS RECEPTOR; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; CAVEOLIN; CAVEOLIN-1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EXTRACELLULAR SIGNAL-REGULATED KINASE 1; GLUTATHIONE TRANSFERASE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASES; TRANS ACTIVATORS; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING SITE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REPORTER GENE; TRANSCRIPTION REGULATION; ANIMAL; CELL CULTURE; CELL NUCLEUS; CELL STRAIN COS1; CERCOPITHECUS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION; PROMOTER REGION; PROTEIN BINDING; SERODIAGNOSIS; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMAL; CAVEOLINS; CELL NUCLEUS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HUMAN; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; P42 MAP KINASE; PHOSPHORYLATION; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 0035477058     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3590203     Document Type: Article

References (62)

1. Molecular chaperones and subcellular trafficking of steroid receptors
2. A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37
3. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
4. Nuclear receptor coactivators
5. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
6. Nuclear receptors: Coactivators, corepressors and chromatin remodeling in the control of transcription
7. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
8. The human estrogen receptor has two independent nonacidic transcriptional activation functions
9. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor
10. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
11. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
12. P300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains
13. Functional domains of the human estrogen receptor
14. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells
15. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region
16. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
17. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element
18. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity
19. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
20. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
21. Two separate mechanisms for ligand-independent activation of the estrogen receptor
22. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167
23. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex
24. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells
25. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1
26. CDK-independent activation of estrogen receptor by cyclin D1
27. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4
28. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
29. Caveolin-1 potentiates estrogen receptor α (ERα) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERα
30. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein
31. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells
32. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein
33. Oligomeric structure of caveolin: Implications for caveolae membrane organization
34. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes
35. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity
36. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor- beta
37. Powerful dominant negative mutants of the human estrogen receptor
38. Cross-talk between peptide growth factor and estrogen receptor signaling pathways
39. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
40. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains
41. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain
42. Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans
43. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro
44. Characterization of ligand-dependent phosphorylation of the estrogen receptor
45. The estrogen receptor beta subtype: A novel mediator of estrogen action in neuroendocrine systems
46. Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
47. Expression of caveolin-3 in skeletal, cardiac and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins
48. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
49. Identification of filamin as a novel ligand for caveolin-1: Evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton
50. VIP21/caveolin is a cholesterol-binding protein
51. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane
52. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking
53. Intracellular cholesterol transport in synchronized human skin fibroblasts
54. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
55. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin
56. Src tyrosine kinases, Gα subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases
57. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins
58. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Gα subunits Gαq and Gαi in caveolae in DDT1 MF-2 smooth muscle cells
59. Regulation of G protein-coupled receptor kinases by caveolin
60. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction
61. Genetic and biochemical analysis of p23 and ansamycin antibiotics in the function of Hsp90-dependent signaling proteins
62. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation